Cellbricks Therapeutics Overview
- Year Founded
-
2015
- Status
-
Private
- Employees
-
30
- Latest Deal Type
-
Seed
- Latest Deal Amount
-
$10M
- Investors
-
15
Cellbricks Therapeutics General Information
Description
Developer of a bio-fabrication platform intended to address the global challenge of organ shortage and the need for improved in-vitro models. The company's platform helps the industrial production of large and complex structures, seamlessly integrating different biomaterials and cell varieties, enabling medical researchers to provide their patients with improved clinical treatments.
Contact Information
Website
www.cellbricks-therapeutics.comCorporate Office
- Müllerstrasse 178
- 13353 Berlin
- Germany
Corporate Office
- Müllerstrasse 178
- 13353 Berlin
- Germany
Cellbricks Therapeutics Timeline
Cellbricks Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 7. Seed Round | 25-Mar-2026 | $10M | Completed | Pre-Clinical Trials | ||
| 6. Accelerator/Incubator | 01-Sep-2024 | Completed | Pre-Clinical Trials | |||
| 5. Seed Round | 23-Apr-2024 | Completed | Pre-Clinical Trials | |||
| 4. Accelerator/Incubator | 01-Jan-2022 | Completed | Product In Beta Test | |||
| 3. Seed Round | 05-Sep-2019 | Completed | Product In Beta Test | |||
| 2. Accelerator/Incubator | Completed | Startup | ||||
| 1. Accelerator/Incubator | 01-Jan-2015 | Completed | Startup |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Cellbricks Therapeutics Comparisons
Industry
Financing
Details
Cellbricks Therapeutics Competitors (7)
One of Cellbricks Therapeutics’s 7 competitors is Treefrog Therapeutics, a Venture Capital-Backed company based in Pessac, France.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Treefrog Therapeutics | Venture Capital-Backed | Pessac, France | ||||
| Trestle Biotherapeutics | Venture Capital-Backed | San Diego, CA | ||||
| Satellite Bio | Venture Capital-Backed | Newton, MA | ||||
| Aspect Biosystems | Venture Capital-Backed | Vancouver, Canada | ||||
| Egenesis | Venture Capital-Backed | Cambridge, MA |
Cellbricks Therapeutics Patents
Cellbricks Therapeutics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2025031537-A1 | Method for producing an ink for 3d printing using a polypeptide based on human collagen with a reduced hydroxyproline content | Inactive | 04-Aug-2023 | ||
| DE-102023120769-A1 | Method for producing an ink for 3d printing using a polypeptide based on human collagen with reduced hydroxyproline content | Active | 04-Aug-2023 | ||
| EP-4501955-A1 | Polypeptide for 3d printing ink | Pending | 04-Aug-2023 | ||
| WO-2025031978-A1 | Polypeptide for an ink for 3d printing | Inactive | 04-Aug-2023 | ||
| DE-102022132519-A1 | 3d adipose tissue scaffold produced by light-based structuring curing for use as breast implant | Pending | 07-Dec-2022 | A61L27/3804 |
Cellbricks Therapeutics Signals
Cellbricks Therapeutics Investors (15)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Invest in Healthcare | Family Office | Minority | ||
| Riceberg Ventures | Venture Capital | Minority | ||
| Silicon Roundabout Ventures | Venture Capital | Minority | ||
| SPRIN-D | Government | |||
| Startup Angels Alb-Bodensee | Angel Group | Minority |
Cellbricks Therapeutics FAQs
-
When was Cellbricks Therapeutics founded?
Cellbricks Therapeutics was founded in 2015.
-
Where is Cellbricks Therapeutics headquartered?
Cellbricks Therapeutics is headquartered in Berlin, Germany.
-
What is the size of Cellbricks Therapeutics?
Cellbricks Therapeutics has 30 total employees.
-
What industry is Cellbricks Therapeutics in?
Cellbricks Therapeutics’s primary industry is Biotechnology.
-
Is Cellbricks Therapeutics a private or public company?
Cellbricks Therapeutics is a Private company.
-
What is Cellbricks Therapeutics’s current revenue?
The current revenue for Cellbricks Therapeutics is .
-
How much funding has Cellbricks Therapeutics raised over time?
Cellbricks Therapeutics has raised $10M.
-
Who are Cellbricks Therapeutics’s investors?
Invest in Healthcare, Riceberg Ventures, Silicon Roundabout Ventures, SPRIN-D, and Startup Angels Alb-Bodensee are 5 of 15 investors who have invested in Cellbricks Therapeutics.
-
Who are Cellbricks Therapeutics’s competitors?
Treefrog Therapeutics, Trestle Biotherapeutics, Satellite Bio, Aspect Biosystems, and Egenesis are some of the 7 competitors of Cellbricks Therapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process